GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » Price-to-Operating-Cash-Flow

Lirum Therapeutics (Lirum Therapeutics) Price-to-Operating-Cash-Flow : (As of Jun. 10, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Lirum Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-10), Lirum Therapeutics's share price is $0.00. Lirum Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.03. Hence, Lirum Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Lirum Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

LRTX's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.02
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Lirum Therapeutics's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.03.

Lirum Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Lirum Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lirum Therapeutics Price-to-Operating-Cash-Flow Chart

Lirum Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - -

Lirum Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Sep23 Dec23
Price-to-Operating-Cash-Flow - - - - -

Competitive Comparison of Lirum Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Lirum Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lirum Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lirum Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Lirum Therapeutics's Price-to-Operating-Cash-Flow falls into.


Lirum Therapeutics Price-to-Operating-Cash-Flow Calculation

Lirum Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.00/-0.029
=

Lirum Therapeutics's Share Price of today is $0.00.
Lirum Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Lirum Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Lirum Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Lirum Therapeutics (Lirum Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lirum Therapeutics Inc (NAS:LRTX) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
Traded in Other Exchanges
N/A
Address
590 Madison Avenue, 21st Floor, New York, NY, USA, 10022
Website
https://www.lirumtx.com
Lirum Therapeutics Inc is clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development, and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways, and commercial opportunities. Its product candidate, LX-101, formerly 765IGF-MTX, is a novel, clinical-stage, "next generation," precision-engineered targeted therapy directed to the IGF-1R.

Lirum Therapeutics (Lirum Therapeutics) Headlines

No Headlines